Plasma hydrazine concentrations in man after isoniazid and hydralazine administration. 1985

I A Blair, and R Mansilla Tinoco, and M J Brodie, and R A Clare, and C T Dollery, and J A Timbrell, and I A Beever

By using a specific sensitive stable-isotope dilution gas chromatography-mass spectrometry (GC-MS) assay, hydrazine was detected in the plasma of eight healthy male volunteer subjects taking isoniazid (300 mg daily) for 2 weeks. Accumulation of hydrazine occurred in slow-acetylator phenotypes. Hydrazine was also detected in the plasma of eight out of 14 hypertensive patients treated chronically with hydralazine (200 mg daily). However, the concentrations of hydrazine observed were much lower than in the isoniazid study and were close to the limit of detection. As hydrazine is hepatotoxic, mutagenic and carcinogenic in animals, its presence in human plasma has important toxicological implications.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007538 Isoniazid Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. Isonicotinic Acid Hydrazide,Ftivazide,Isonex,Isonicotinic Acid Vanillylidenehydrazide,Phthivazid,Phthivazide,Tubazide,Acid Vanillylidenehydrazide, Isonicotinic,Hydrazide, Isonicotinic Acid,Vanillylidenehydrazide, Isonicotinic Acid
D008297 Male Males
D008401 Gas Chromatography-Mass Spectrometry A microanalytical technique combining mass spectrometry and gas chromatography for the qualitative as well as quantitative determinations of compounds. Chromatography, Gas-Liquid-Mass Spectrometry,Chromatography, Gas-Mass Spectrometry,GCMS,Spectrometry, Mass-Gas Chromatography,Spectrum Analysis, Mass-Gas Chromatography,Gas-Liquid Chromatography-Mass Spectrometry,Mass Spectrometry-Gas Chromatography,Chromatography, Gas Liquid Mass Spectrometry,Chromatography, Gas Mass Spectrometry,Chromatography, Mass Spectrometry-Gas,Chromatography-Mass Spectrometry, Gas,Chromatography-Mass Spectrometry, Gas-Liquid,Gas Chromatography Mass Spectrometry,Gas Liquid Chromatography Mass Spectrometry,Mass Spectrometry Gas Chromatography,Spectrometries, Mass-Gas Chromatography,Spectrometry, Gas Chromatography-Mass,Spectrometry, Gas-Liquid Chromatography-Mass,Spectrometry, Mass Gas Chromatography,Spectrometry-Gas Chromatography, Mass,Spectrum Analysis, Mass Gas Chromatography
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006830 Hydralazine A direct-acting vasodilator that is used as an antihypertensive agent. Hydrallazin,Apresoline,Apressin,Apressoline,Hydralazine Hydrochloride,Hydralazine mono-Hydrochloride,Hydrazinophthalazine,Nepresol,Hydralazine mono Hydrochloride,Hydrochloride, Hydralazine,mono-Hydrochloride, Hydralazine
D006834 Hydrazines Substituted derivatives of hydrazine (formula H2N-NH2). Hydrazide
D000107 Acetylation Formation of an acetyl derivative. (Stedman, 25th ed) Acetylations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

I A Blair, and R Mansilla Tinoco, and M J Brodie, and R A Clare, and C T Dollery, and J A Timbrell, and I A Beever
August 1983, Journal of pharmaceutical sciences,
I A Blair, and R Mansilla Tinoco, and M J Brodie, and R A Clare, and C T Dollery, and J A Timbrell, and I A Beever
May 1988, British journal of clinical pharmacology,
I A Blair, and R Mansilla Tinoco, and M J Brodie, and R A Clare, and C T Dollery, and J A Timbrell, and I A Beever
February 1996, The Tokai journal of experimental and clinical medicine,
I A Blair, and R Mansilla Tinoco, and M J Brodie, and R A Clare, and C T Dollery, and J A Timbrell, and I A Beever
August 1983, Journal of pharmaceutical sciences,
I A Blair, and R Mansilla Tinoco, and M J Brodie, and R A Clare, and C T Dollery, and J A Timbrell, and I A Beever
January 1966, Annali dell'Istituto "Carlo Forlanini",
I A Blair, and R Mansilla Tinoco, and M J Brodie, and R A Clare, and C T Dollery, and J A Timbrell, and I A Beever
April 1977, British journal of urology,
I A Blair, and R Mansilla Tinoco, and M J Brodie, and R A Clare, and C T Dollery, and J A Timbrell, and I A Beever
November 2001, Annals of internal medicine,
I A Blair, and R Mansilla Tinoco, and M J Brodie, and R A Clare, and C T Dollery, and J A Timbrell, and I A Beever
March 1992, Xenobiotica; the fate of foreign compounds in biological systems,
I A Blair, and R Mansilla Tinoco, and M J Brodie, and R A Clare, and C T Dollery, and J A Timbrell, and I A Beever
January 1977, Arzneimittel-Forschung,
I A Blair, and R Mansilla Tinoco, and M J Brodie, and R A Clare, and C T Dollery, and J A Timbrell, and I A Beever
April 1985, Experimental and clinical endocrinology,
Copied contents to your clipboard!